Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Sitagliptin")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 176

  • Page / 8
Export

Selection :

  • and

Simultaneous Determination of Sitagliptin and Metformin in Their Pharmaceutical FormulationREZK, Mamdouh R; RIAD, Safa'a M; MAHMOUD, Ghada Y et al.Journal of AOAC International. 2013, Vol 96, Num 2, pp 301-306, issn 1060-3271, 6 p.Article

Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitorMAS-VIDAL, Albert; SANTOS-JUANES, Jorge; ESTEVE-MARTINEZ, Altea et al.Australasian journal of dermatology. 2012, Vol 53, Num 1, pp 70-72, issn 0004-8380, 3 p.Article

Functional Expression and Characterization of Dipeptidyl Peptidase IV from the Black-Bellied Hornet Vespa basalis in Sf21 Insect CellsHSIEH, Sheng-Kuo; TZEN, Jason T. C; WU, Tzong-Yuan et al.Bioscience, biotechnology, and biochemistry. 2011, Vol 75, Num 12, pp 2371-2375, issn 0916-8451, 5 p.Article

Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinelics of the sulphonylurea, glyburide, in healthy subjectsMISTRY, Goutam C; BERGMAN, Arthur J; WEI ZHENG et al.British journal of clinical pharmacology. 2008, Vol 66, Num 1, pp 36-42, issn 0306-5251, 7 p.Article

Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitisYILMAZ, Yusuf; YONAL, Oya; DEYNELI, Oguzhan et al.Acta gastro-enterologica belgica (English ed.). 2012, Vol 75, Num 2, pp 240-244, issn 1784-3227, 5 p.Article

Non-Alcoholic Fatty Liver Disease Adversely Affects the Glycemic Control Afforded by SitagliptinIWASAK, Tomoyuki; TOMENO, Wataru; YONEDA, Masato et al.Hepato-gastroenterology. 2012, Vol 59, Num 117, pp 1522-1525, issn 0172-6390, 4 p.Article

Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in MiceWAGET, Aurélie; CABOU, Cendrine; SULPICE, Thierry et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 8, pp 3018-3029, issn 0013-7227, 12 p.Article

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetesASCHNER, Pablo; MICKEL, Carolyn; KIPNES, Mark S et al.Diabetes care. 2006, Vol 29, Num 12, pp 2632-2637, issn 0149-5992, 6 p.Article

Novel Biological Action of the Dipeptidylpeptidase-IV Inhibitor, Sitagliptin, as a Glucagon-Like Peptide-1 SecretagogueSANGLE, Ganesh V; LAUFFER, Lina M; GRIECO, Anthony et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 2, pp 564-573, issn 0013-7227, 10 p.Article

Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humansVINCENT, Stella H; REED, James R; DILZER, Stacy et al.Drug metabolism and disposition. 2007, Vol 35, Num 4, pp 533-538, issn 0090-9556, 6 p.Article

Characterization of two cyclic metabolites of sitagliptinLIU, David Q; ARISON, Byron H; STEARNS, Ralph A et al.Drug metabolism and disposition. 2007, Vol 35, Num 4, pp 521-524, issn 0090-9556, 4 p.Article

Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes MellitusJIN AH JUNG; KAKU, Kohei; JAE HYEON KIM et al.Advances in therapy. 2013, Vol 30, Num 11, pp 1018-1029, issn 0741-238X, 12 p.Article

Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetesVAGHASIYA, Jitendra; SHETH, Navin; BHALODIA, Yagnik et al.Regulatory peptides. 2011, Vol 166, Num 1-3, pp 48-54, issn 0167-0115, 7 p.Article

Sitagliptin. CommentaryLYSENG-WILLIAMSON, Katherine A; RAZ, Itamar; KIPNES, Mark S et al.Drugs (Basel). 2007, Vol 67, Num 4, pp 587-599, issn 0012-6667, 13 p.Article

Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes MellitusIWASAKI, Tomoyuki; YONEDA, Masato; INAMORI, Masahiko et al.Hepato-gastroenterology. 2011, Vol 58, Num 112, pp 2103-2105, issn 0172-6390, 3 p.Article

L'ÉTUDE CLINIQUE DU MOIS: SUGAR: résultats d'une étude observationnelle belge concernant l'utilisation de la sitagliptine chez des patients diabétiques de type 2 = SUGAR: RESULTS OF A BELGIAN OBSERVATIONAL STUDY ON THE USE OF SITAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETESSCHEEN, A. J; VAN GAAL, L. F.RMLG. Revue médicale de Liège. 2010, Vol 65, Num 3, issn 0370-629X, 127-132 [6 p.]Article

LE MÉDICAMENT DU MOIS Combinaison fixe sitagliptine-metformine (Janumet®) = SITAGLIPTIN-METFORMIN FIXED COMBINATION (JANUMET®)SCHEEN, A. J.RMLG. Revue médicale de Liège. 2010, Vol 65, Num 11, issn 0370-629X, 648-654 [7 p.]Article

Sitagliptin Phosphate : A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes MellitusZERILLI, Tina; PYON, Eunice Y.Clinical therapeutics. 2007, Vol 29, Num 12, pp 2614-2634, issn 0149-2918, 21 p.Article

Inhibition of anaphylaxis like reaction and mast cell activation by SitagliptinNADER, Manar A.International immunopharmacology (Print). 2011, Vol 11, Num 8, pp 1052-1056, issn 1567-5769, 5 p.Article

Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2-year study evaluationDEROSA, Giuseppe; RAGONESI, Pietro Dario; FOGARI, Elena et al.Fundamental & clinical pharmacology. 2014, Vol 28, Num 2, pp 221-229, issn 0767-3981, 9 p.Article

Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysisQIANG DU; BO WU; WANG, Yan-Jun et al.Current medical research and opinion. 2013, Vol 29, Num 11, pp 1487-1494, issn 0300-7995, 8 p.Article

The dipeptidyl peptidase-4 inhibitor-sitagliptin modulates calcium dysregulation, inflammation, and PPARs in hypertensive cardiomyocytesLEE, T.-I; KAO, Y.-H; CHEN, Y.-C et al.International journal of cardiology. 2013, Vol 168, Num 6, pp 5390-5395, issn 0167-5273, 6 p.Article

Prise en charge d'un diabète insulinotraité Intérêt des IDPP4COSSON, Emmanuel.Diabète & obésité. 2013, Vol 8, Num 70, pp 178-181, issn 1957-5238, 4 p.Article

Drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient taking sitagliptinSIN, C; MAHE, E; SIGAL, M.-L et al.Diabetes & metabolism. 2012, Vol 38, Num 6, pp 571-573, issn 1262-3636, 3 p.Article

Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI—Trial) — Rationale, design and first interim analysisTHEISS, Hans D; BRENNER, Christoph; FRANZ, Wolfgang-M et al.International journal of cardiology. 2010, Vol 145, Num 2, pp 282-284, issn 0167-5273, 3 p.Article

  • Page / 8